2006, Neurotransmitters and mental health and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2006

Neurotransmitters and mental health

Pharmaceuticals

Summing up the STAR*D Scandal: The Public was Betrayed, Millions were Harmed, and the Mainstream Media Failed Us All

Mad in America

JANUARY 4, 2025

As such, the scandal now serves as a historical verdict on the ethics of American psychiatry, and by extension, the National Institute of Mental Health (NIMH). In 2006, the American Journal of Psychiatry (AJP) published four reports on STAR*D outcomes. There was one other red flag.

Pharmaceuticals

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

OCTOBER 18, 2023

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. This applies in the mental illness world and everywhere in medicine.

Pharmaceuticals

Pharmaceuticals Manufacturing Healthcare Neurotransmitters and mental health

Mental Health Clinicians

Summing up the STAR*D Scandal: The Public was Betrayed, Millions were Harmed, and the Mainstream Media Failed Us All

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Stay Connected